{"analyses":[{"ciNumSides":"TWO_SIDED","groupDescription":"Gray's estimate. (Fine and Gray). Null hypothesis is all four groups are statistically from the same population. Alternative hypothesis is that at least one of the groups is from a population different from the remaining groups. Anticipated sample-sizes comparing Active ALL (anticipated N= 12) with the combined AML patients (anticipated N=38) was deemed to be too small for formal hypothesis testing","groupIds":["OG000","OG001","OG002","OG003"],"nonInferiorityComment":"Given the small sample-size of the disease sub-groups, this was a hypothesis generating study.","nonInferiorityType":"EQUIVALENCE","pValue":">0.05","pValueComment":"Not adjusted for multiple comparisons. A-priori threshold for statistical significance was 0.05.","paramType":"Median Difference (Net)","paramValue":"0","statisticalComment":"No adjustments.","statisticalMethod":"Gray's Test"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0","upperLimit":"0","value":"0"},{"groupId":"OG001","lowerLimit":"0","upperLimit":"0","value":"0"},{"groupId":"OG002","lowerLimit":"9","upperLimit":"65","value":"30"},{"groupId":"OG003","lowerLimit":"13","upperLimit":"87","value":"50"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"10"},{"groupId":"OG003","value":"6"}],"units":"Participants"}],"description":"Fine and Gray estimate of cumulative incidence of Relapse, with Death as the competing risk. Estimate is at five years post-transplant. Ninety-five percent confidence interval is by logit transformation of Greenwood variance to keep the interval within the probability space of 0% to 100%.","dispersionType":"95% Confidence Interval","groups":[{"description":"Acute Myelogenous Leukemia Transplanted in First Complete Remission","id":"OG000","title":"AML/1CR"},{"description":"Acute Myelogenous Leukemia Transplanted in First Relapse","id":"OG001","title":"AML/R1"},{"description":"Acute Myelogenous Leukemia Transplanted in Induction Failure","id":"OG002","title":"AML/IF"},{"description":"Active Acute Lymphocytic Leukemia","id":"OG003","title":"Active ALL"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Date of Transplant to Five Years post-Transplant. Estimate is at Five Years post-Transplant.","title":"Cumulative Incidence of Relapse With Transplant-related Death as the Competing Risk: Diagnosis Groups Are Compared.","type":"PRIMARY","unitOfMeasure":"percentage of relapse probability"}